Antibiotic Lock for Dialysis Catheter
For treating dialysis catheter-related bloodstream infections, use vancomycin 5.0 mg/mL combined with 2500-5000 IU/mL heparin as the antibiotic lock solution, instilled into each catheter lumen after every dialysis session for 10-14 days, always in conjunction with systemic antibiotics. 1
Pathogen-Specific Lock Solutions
The choice of antibiotic lock depends on the identified organism:
For Gram-Positive Organisms
Methicillin-resistant staphylococci (MRSA/MRSE): Vancomycin 5.0 mg/mL with 2500-5000 IU/mL heparin 1
Methicillin-susceptible staphylococci (MSSA/MSSE): Cefazolin 5.0 mg/mL with 2500-5000 IU/mL heparin 1
Enterococcus species:
For Gram-Negative Organisms
- Gentamicin 1.0 mg/mL with 2500 IU/mL heparin 1
- Ceftazidime 0.5 mg/mL with 100 IU/mL heparin 1
- Ciprofloxacin 0.2 mg/mL with 5000 IU/mL heparin (limited by precipitation at higher concentrations) 1
For Mixed Infections
- Ethanol 70% without heparin can be considered for mixed gram-positive and gram-negative infections 1
Systemic Antibiotic Therapy (Concurrent)
Antibiotic lock must never be used alone—always combine with systemic antibiotics 1:
Empirical Therapy (Pending Cultures)
Vancomycin 20 mg/kg loading dose during the last hour of dialysis, then 500 mg during the last 30 minutes of each subsequent session 1
PLUS gram-negative coverage:
- Gentamicin 1 mg/kg (max 100 mg) after each dialysis session, OR
- Ceftazidime 1 g IV after each session 1
In units with low MRSA prevalence, cefazolin 20 mg/kg IV after each session may replace vancomycin 1
Administration Protocol
Dwell Time
- Hemodialysis patients: Renew lock solution after each dialysis session (typically 48-72 hours between sessions) 1
- The lock should remain in the catheter lumen between dialysis treatments 1
Duration
- 10-14 days total for both systemic antibiotics and lock therapy 1
Volume
- Use sufficient volume to fill the catheter lumen, typically 2-5 mL per lumen 1
Critical Caveats and Contraindications
When Catheter Removal is Mandatory
Remove the catheter immediately rather than attempting salvage in these situations:
Staphylococcus aureus infection - Success rate only 40-55%, with high complication rates 1, 2
- In one quality improvement study, 59% of S. aureus cases failed lock therapy, and 25% of those with persistent fever developed serious complications (endocarditis, osteomyelitis) 2
Candida species - Antibiotic lock is ineffective for fungal biofilms 1
Exit site or tunnel infection - Lock therapy cannot reach extraluminal infections 1
Persistent fever >48 hours after initiating therapy - This predicts treatment failure and serious complications 2
Recurrent bacteremia within 90 days 2
Success Rates by Organism
The evidence shows marked variation in efficacy:
- Gram-negative pathogens: 87-100% success 1
- Coagulase-negative staphylococci: 75-84% success 1
- S. aureus: Only 40-55% success 1, 2
- Enterococcus: 61% success rate 3
Preparation Considerations
- Vancomycin precipitation: When mixing 10 mg/mL vancomycin with 10,000 IU/mL heparin, precipitation occurs but resolves with 10 seconds of agitation; solution remains stable for 72 hours at 37°C 1
- All listed concentrations are verified not to precipitate at the specified heparin concentrations 1
Clinical Decision Algorithm
- Obtain blood cultures from catheter and peripheral site simultaneously
- Start empirical systemic antibiotics immediately (vancomycin + gram-negative coverage)
- Initiate empirical vancomycin lock (5.0 mg/mL) after first dialysis session
- Assess at 48 hours: If fever persists → remove catheter
- Tailor therapy once cultures available:
- S. aureus or Candida → remove catheter
- Coagulase-negative staph or gram-negatives → continue lock + systemic therapy
- Enterococcus → continue with vancomycin or ampicillin lock based on susceptibility
- Complete 10-14 days of combined therapy if salvage successful
- Monitor for 90 days for recurrence
This approach balances the logistical challenges of catheter replacement in dialysis patients (limited access sites, venous stenosis risk, need for urgent replacement) 1 against the substantial mortality and morbidity risks of inadequately treated catheter infections.